Poems Syndrome
📧 Sign up to get email alerts when something new happens for Poems Syndrome.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-04Clinical Trial Update: One Gene, Two Diseases: the Pathologic Role of IGLV1-44 in AL Amyloidosis and POEMS
A clinical trial evaluating the pathologic role of the gene IGLV1-44 in AL amyloidosis and POEMS syndrome is currently recruiting.
-
CLINICAL_TRIALS research · 2026-02-23Clinical Trial Update: Gut Microbiome Studies in Patients With POEMS Syndrome and Other Plasma Cell Disorders
A Mayo Clinic-sponsored clinical trial is evaluating the gut microbiome in patients with POEMS syndrome and other plasma cell disorders; rec…
-
CLINICAL_TRIALS research · 2025-11-20Clinical Trial Update: Registry for Adults With Plasma Cell Disorders (PCD's)
Clinical trial registry update for adults with plasma cell disorders indicating active recruitment. The study is sponsored by UNC Lineberger…
-
CLINICAL_TRIALS research · 2025-08-11Clinical Trial Update: BCMA/CD3 BsAb Therapy for POEMS Syndrome [Phase 2]
Phase 2 clinical trial testing a BCMA/CD3 bispecific antibody therapy for POEMS syndrome; the study is not yet recruiting.
-
CLINICAL_TRIALS research · 2025-04-06Clinical Trial Update: Polyneuropathy, Impairments and Physical Activity - The PolyImPAct Study
A clinical trial update for the PolyImPAct study investigating polyneuropathy, impairments, and physical activity, currently recruiting and …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-10-30Clinical Trial Update: Safety and Efficacy of CT103A Cells for Relapsed/Refractory Antibody-associated Inflammatory Diseases of the Nervous System [EARLY_Phase 1]
An early-phase clinical trial is investigating CT103A cell therapy for relapsed/refractory antibody-associated inflammatory diseases of the …
-
CLINICAL_TRIALS research · 2024-07-24Clinical Trial Update: A Study of KQ-2003 CAR-T Cell Therapy for Patients With Relapsed or Refractory POEMS Syndrome [Phase 1]
This update announces a Phase 1 clinical trial of KQ-2003 CAR-T cell therapy for relapsed or refractory POEMS syndrome, which is not yet rec…